• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪甲苷通过阻断 mTORC1/p70S6K 信号通路改善高糖诱导的 HK-2 细胞肾小管上皮细胞-间充质转化。

Astragaloside IV ameliorates high glucose‑induced renal tubular epithelial‑mesenchymal transition by blocking mTORC1/p70S6K signaling in HK‑2 cells.

机构信息

Department of Pharmacy, The People's Hospital of Jiangyin, Jiangyin, Jiangsu 214400, P.R. China.

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China.

出版信息

Int J Mol Med. 2019 Feb;43(2):709-716. doi: 10.3892/ijmm.2018.3999. Epub 2018 Nov 26.

DOI:10.3892/ijmm.2018.3999
PMID:30483732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6317658/
Abstract

Astragaloside IV (AST) is the major active saponin in Astragalus membranaceus and, reportedly, has a variety of pharmacological activities. However, the potential of AST to ameliorate high glucose‑mediated renal tubular epithelial‑mesenchymal transition (EMT) remains undetermined. The aim of the present research was to explore the effect and mechanism of AST in EMT of renal tubular epithelial cells, as an underlying mechanism of renal fibrosis and a vital feature involved in diabetic nephropathy. The effect of AST on the EMT of renal tubular epithelial cells (HK‑2) stimulated by high glucose was investigated and it was attempted to elucidate the potential underlying mechanism. The expression of E‑cadherin and α‑smooth muscle actin were determined by western blotting and immunofluorescence assays. The expression of the mammalian target of rapamycin complex 1 (mTORC1)/ ribosomal protein S6 kinase β‑1 (p70S6K) signaling pathway and protein levels of four transcriptional factors (snail, slug, twist and zinc finger E‑box‑binding homeobox 1) were also determined by western blotting. Additionally, extracellular matrix components, including fibronectin (FN) and collagen type IV (Col IV) were detected by ELISA. The results suggested that the EMT of HK‑2 cells and the mTORC1/p70S6K pathway were activated by high glucose. The expression of snail and twist in HK‑2 cells was elevated by high glucose. Furthermore, extracellular matrix components, FN and Col IV, were increased in HK‑2 cells cultured with high glucose. In turn, treatment with AST reduced EMT features in HK‑2 cells, inhibited mTORC1/p70S6K pathway activation, downregulated expression of snail and twist, and reduced secretion of FN and Col IV. In summary, the findings suggested that AST ameliorates high glucose‑mediated renal tubular EMT by blocking the mTORC1/p70S6K signaling pathway in HK‑2 cells.

摘要

黄芪甲苷(AST)是黄芪中的主要活性皂苷,据报道具有多种药理活性。然而,AST 改善高糖介导的肾小管上皮-间充质转化(EMT)的潜力尚未确定。本研究旨在探讨 AST 对高糖刺激的肾小管上皮细胞(HK-2)EMT 的作用及其机制,这是肾脏纤维化的潜在机制,也是糖尿病肾病的重要特征。研究了 AST 对高糖诱导的肾小管上皮细胞 EMT 的影响,并试图阐明其潜在机制。通过 Western blot 和免疫荧光法测定 E-钙黏蛋白和α-平滑肌肌动蛋白的表达。Western blot 还测定了雷帕霉素复合物 1(mTORC1)/核糖体蛋白 S6 激酶β-1(p70S6K)信号通路和四个转录因子(snail、slug、twist 和锌指 E-盒结合同源框 1)的蛋白水平。此外,通过 ELISA 检测细胞外基质成分,包括纤维连接蛋白(FN)和 IV 型胶原(Col IV)。结果表明,高糖激活了 HK-2 细胞的 EMT 和 mTORC1/p70S6K 通路。高糖可上调 HK-2 细胞中 snail 和 twist 的表达。此外,高糖培养的 HK-2 细胞中细胞外基质成分 FN 和 Col IV 增加。AST 处理可减少 HK-2 细胞 EMT 特征,抑制 mTORC1/p70S6K 通路激活,下调 snail 和 twist 的表达,并减少 FN 和 Col IV 的分泌。综上所述,AST 通过阻断 HK-2 细胞中的 mTORC1/p70S6K 信号通路改善高糖介导的肾小管 EMT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/46a62f4ec880/IJMM-43-02-0709-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/7ed5dbbb5432/IJMM-43-02-0709-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/25dbebcd2611/IJMM-43-02-0709-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/10019002b3f0/IJMM-43-02-0709-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/072d3aaf435f/IJMM-43-02-0709-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/ae7f8b7aa2d2/IJMM-43-02-0709-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/46a62f4ec880/IJMM-43-02-0709-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/7ed5dbbb5432/IJMM-43-02-0709-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/25dbebcd2611/IJMM-43-02-0709-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/10019002b3f0/IJMM-43-02-0709-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/072d3aaf435f/IJMM-43-02-0709-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/ae7f8b7aa2d2/IJMM-43-02-0709-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcc/6317658/46a62f4ec880/IJMM-43-02-0709-g05.jpg

相似文献

1
Astragaloside IV ameliorates high glucose‑induced renal tubular epithelial‑mesenchymal transition by blocking mTORC1/p70S6K signaling in HK‑2 cells.黄芪甲苷通过阻断 mTORC1/p70S6K 信号通路改善高糖诱导的 HK-2 细胞肾小管上皮细胞-间充质转化。
Int J Mol Med. 2019 Feb;43(2):709-716. doi: 10.3892/ijmm.2018.3999. Epub 2018 Nov 26.
2
Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.槲皮素抑制mTORC1/p70S6K信号介导的糖尿病肾病肾小管上皮细胞-间充质转化和肾纤维化。
Pharmacol Res. 2015 Sep;99:237-47. doi: 10.1016/j.phrs.2015.06.006. Epub 2015 Jul 4.
3
Silencing of angiotensin II type-1 receptor inhibits high glucose-induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells via inactivation of mTOR/p70S6K signaling pathway.血管紧张素II 1型受体沉默通过使mTOR/p70S6K信号通路失活抑制高糖诱导的人肾近端小管上皮细胞上皮-间质转化。
Biochem Biophys Res Commun. 2016 Jan 8;469(2):183-8. doi: 10.1016/j.bbrc.2015.11.092. Epub 2015 Nov 26.
4
Procyanidin B2 inhibits high glucose‑induced epithelial‑mesenchymal transition in HK‑2 human renal proximal tubular epithelial cells.原花青素B2抑制高糖诱导的HK-2人肾近端小管上皮细胞上皮-间质转化。
Mol Med Rep. 2015 Dec;12(6):8148-54. doi: 10.3892/mmr.2015.4445. Epub 2015 Oct 15.
5
Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.TSC1 的失活促进了小鼠糖尿病肾病肾小管上皮细胞的上皮-间充质转化。
Acta Pharmacol Sin. 2019 Dec;40(12):1555-1567. doi: 10.1038/s41401-019-0244-6. Epub 2019 Jun 24.
6
Etoposide-induced protein 2.4 ameliorates high glucose-induced epithelial-mesenchymal transition by activating adenosine monophosphate-activated protein kinase pathway in renal tubular cells.依托泊苷诱导蛋白 2.4 通过激活肾小管细胞中的单磷酸腺苷激活的蛋白激酶通路改善高糖诱导的上皮-间充质转化。
Int J Biochem Cell Biol. 2022 Jan;142:106117. doi: 10.1016/j.biocel.2021.106117. Epub 2021 Nov 19.
7
Alterations in tubular epithelial cells in diabetic nephropathy.糖尿病肾病中肾小管上皮细胞的改变。
J Nephrol. 2013 Sep-Oct;26(5):865-9. doi: 10.5301/jn.5000287. Epub 2013 Aug 6.
8
Effects of Astragaloside IV Against the TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Peritoneal Mesothelial Cells by Promoting Smad 7 Expression.黄芪甲苷IV通过促进Smad 7表达对转化生长因子-β1诱导的腹膜间皮细胞上皮-间质转化的影响
Cell Physiol Biochem. 2015;37(1):43-54. doi: 10.1159/000430332. Epub 2015 Aug 12.
9
BMP-7/Smads-induced inhibitor of differentiation 2 (Id2) upregulation and Id2/Twist interaction was involved in attenuating diabetic renal tubulointerstitial fibrosis.BMP-7/Smads 诱导的分化抑制因子 2(Id2)上调,以及 Id2/Twist 相互作用参与了糖尿病肾间质纤维化的减轻。
Int J Biochem Cell Biol. 2019 Nov;116:105613. doi: 10.1016/j.biocel.2019.105613. Epub 2019 Sep 17.
10
Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.血管紧张素 AT1 受体激活介导高糖诱导的肾近端小管细胞上皮-间充质转化。
Clin Exp Pharmacol Physiol. 2010 Sep;37(9):e152-7. doi: 10.1111/j.1440-1681.2010.05421.x. Epub 2010 Jun 25.

引用本文的文献

1
The Potential of Naturally Derived Compounds for Treating Chronic Kidney Disease: A Review of Autophagy and Cellular Senescence.天然衍生化合物治疗慢性肾脏病的潜力:自噬与细胞衰老综述
Int J Mol Sci. 2024 Dec 24;26(1):3. doi: 10.3390/ijms26010003.
2
Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism.黄芪及其提取物治疗糖尿病肾病的疗效及分子机制。
J Diabetes Res. 2024 Sep 14;2024:5216113. doi: 10.1155/2024/5216113. eCollection 2024.
3
A systematic review of astragaloside IV effects on animal models of diabetes mellitus and its complications.

本文引用的文献

1
Inhibition of Akt/mTOR/p70S6K Signaling Activity With Huangkui Capsule Alleviates the Early Glomerular Pathological Changes in Diabetic Nephropathy.黄葵胶囊抑制Akt/mTOR/p70S6K信号活性减轻糖尿病肾病早期肾小球病理改变
Front Pharmacol. 2018 May 23;9:443. doi: 10.3389/fphar.2018.00443. eCollection 2018.
2
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.西格列汀通过阻断 TGF-β1/Smad 信号通路改善糖尿病肾病。
Int J Mol Med. 2018 May;41(5):2784-2792. doi: 10.3892/ijmm.2018.3504. Epub 2018 Feb 16.
3
Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
黄芪甲苷对糖尿病动物模型及其并发症影响的系统评价
Heliyon. 2024 Feb 22;10(5):e26863. doi: 10.1016/j.heliyon.2024.e26863. eCollection 2024 Mar 15.
4
The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications.黄芪甲苷治疗糖尿病及其并发症的抗炎作用的分子基础。
Drug Des Devel Ther. 2023 Mar 10;17:771-790. doi: 10.2147/DDDT.S399423. eCollection 2023.
5
Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy.黑地黄丸通过抑制自噬减轻5/6肾切除大鼠的肾纤维化。
Front Pharmacol. 2022 Sep 9;13:977284. doi: 10.3389/fphar.2022.977284. eCollection 2022.
6
: A review of its anti-fibrosis properties.对其抗纤维化特性的综述。
Front Pharmacol. 2022 Sep 7;13:976561. doi: 10.3389/fphar.2022.976561. eCollection 2022.
7
Natural products: potential drugs for the treatment of renal fibrosis.天然产物:治疗肾纤维化的潜在药物。
Chin Med. 2022 Aug 17;17(1):98. doi: 10.1186/s13020-022-00646-z.
8
Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis Inhibiting the AT1R/CK2/NF-κB Pathway.龙胆苦苷通过抑制AT1R/CK2/NF-κB信号通路改善糖尿病肾小管间质纤维化
Front Pharmacol. 2022 Jun 23;13:848915. doi: 10.3389/fphar.2022.848915. eCollection 2022.
9
Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis.中药干预肾间质纤维化的研究进展
Front Pharmacol. 2022 Jun 13;13:900491. doi: 10.3389/fphar.2022.900491. eCollection 2022.
10
Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function.CB1 受体在调节肾小管功能方面的 mTORC1 介导的相反生理和病理作用。
Nat Commun. 2022 Apr 4;13(1):1783. doi: 10.1038/s41467-022-29124-8.
黄芪甲苷通过抑制 PI3K/Akt/NF-κB 通路抑制 TGF-β1 诱导的胃癌细胞上皮-间质转化。
Phytother Res. 2018 Jul;32(7):1289-1296. doi: 10.1002/ptr.6057. Epub 2018 Feb 26.
4
Astragaloside IV Inhibits Adipose Lipolysis and Reduces Hepatic Glucose Production Akt Dependent PDE3B Expression in HFD-Fed Mice.黄芪甲苷IV抑制高脂饮食喂养小鼠的脂肪分解并减少肝脏葡萄糖生成:Akt依赖性PDE3B表达
Front Physiol. 2018 Jan 23;9:15. doi: 10.3389/fphys.2018.00015. eCollection 2018.
5
Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure.黄芪甲苷抑制慢性心力衰竭大鼠心室重构并改善脂肪酸利用。
Biosci Rep. 2018 May 22;38(3). doi: 10.1042/BSR20171036. Print 2018 May 29.
6
NRF2/HO-1 activation via ERK pathway involved in the anti-neuroinflammatory effect of Astragaloside IV in LPS induced microglial cells.通过ERK途径激活NRF2/HO-1参与黄芪甲苷对脂多糖诱导的小胶质细胞的抗神经炎症作用。
Neurosci Lett. 2018 Feb 14;666:104-110. doi: 10.1016/j.neulet.2017.12.039. Epub 2017 Dec 19.
7
Astragaloside IV protects rat retinal capillary endothelial cells against high glucose-induced oxidative injury.黄芪甲苷IV保护大鼠视网膜毛细血管内皮细胞免受高糖诱导的氧化损伤。
Drug Des Devel Ther. 2017 Dec 13;11:3567-3577. doi: 10.2147/DDDT.S152489. eCollection 2017.
8
Sitagliptin ameliorates high glucose-induced cell proliferation and expression of the extracellular matrix in glomerular mesangial cells.西他列汀可改善高糖诱导的肾小球系膜细胞增殖及细胞外基质表达。
Exp Ther Med. 2017 Oct;14(4):3862-3867. doi: 10.3892/etm.2017.5002. Epub 2017 Aug 22.
9
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.GLP-1 与肾脏:从生理学到药理学以及在糖尿病中的结局。
Nat Rev Nephrol. 2017 Oct;13(10):605-628. doi: 10.1038/nrneph.2017.123. Epub 2017 Sep 4.
10
A New Chapter for Diabetic Kidney Disease.糖尿病肾病的新篇章。
N Engl J Med. 2017 Aug 31;377(9):885-887. doi: 10.1056/NEJMe1708949.